Vanguard Global Advisers »

Kala Pharmaceuticals shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Kala Pharmaceuticals (KALA) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Kala Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kala Pharmaceuticals held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kala Pharmaceuticals by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $144 832 0.17

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Kala Pharmaceuticals

Citadel Advisors
Geode Capital Management
ADAR1 Capital Management
Vanguard Group
Virtu Financial
GSA Capital Partners
UBS Group
Vanguard Capital Management
Renaissance Technologies
Jane Street
Vanguard Fiduciary Trust
State Street Corporation
XTX Topco
Grant Private Wealth Management
Greenwich Wealth Management

View all funds holding Kala Pharmaceuticals